Skip to main content

Table 3 Baseline characteristics, after matching

From: Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer

 

Cohort iC + CRT

Cohort CRT

45–55 Gy

55+ Gy

 

45–55 Gy

55+ Gy

 

N

%

N

%

P

N

%

N

%

P

Facility1

0.26

 Nonacademic

129

50

65

50

 

273

75

128

70

 

 Academic

129

50

64

50

 

93

25

55

30

 

Age

0.91

    

0.59

 < 65

128

50

65

50

 

196

54

93

51

 

 ≥ 65

130

50

64

50

 

170

46

90

49

 

Charlson-Deyo Score

0.65

    

0.48

 0–1

242

94

123

95

 

351

96

178

97

 

 ≥ 2

16

6

6

5

 

15

4

5

3

 

Income

0.65

 Above median

    

205

56

107

58

 

 Below median

    

161

44

76

42

 

Year of diagnosis

0.71

    

0.85

 2004–2007

10

4

5

4

 

133

36

71

39

 

 2008–2011

131

51

71

55

 

177

48

86

47

 

 2012–2015

117

45

53

41

 

56

15

26

14

 

Tumor size (cm)

0.67

    

0.78

 < 3.8

137

53

65

50

 

161

44

78

43

 

 ≥ 3.8

121

47

64

50

 

205

56

105

57

 

Clinical N stage

   

0.58

    

0.51

 0

160

62

84

65

 

224

61

118

64

 

 1

98

38

45

35

 

142

39

65

36

 

Chemotherapy

0.59

    

0.54

 Single agent

49

19

28

22

 

273

75

132

72

 

 Multi agent

209

81

101

78

 

93

25

51

28

 
  1. iC induction chemotherapy, CRT chemoradiation